You are here

Meeting Highlights

Highlights of the American Stroke Association’s 29th International Stroke Conference

Lawrence M. Prescott, PhD
PDF version: 
Dr. Prescott reports on a combined thrombolytic/glycoprotein receptor blocker therapy for middle cerebral artery occlusion, a thrombin inhibitor, a low-dose thrombolytic agent, an astrocyte activation modulator, a new investigational agent, amphetamine therapy plus physiotherapy, statins for brain infarction, and recombinant factor VIIa for correcting warfarin anticoagulation.